San Francisco-based telehealth platform Hims & Hers Health (HIMS) has expanded its mental health services with individual online therapy. The company provides personalized wellness and health services.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Available at $99 per session, the new individualized therapy offering provides more convenience, comfort, and cost-savings to mental health services. Patients can use the service to connect with licensed therapists via video calls.
The CEO of Hims & Hers, Andrew Dudum, said, “I’m incredibly proud of the team here at Hims & Hers for developing a platform that takes the fear and guesswork out of therapy without sacrificing the high standards of care we uphold across our entire telehealth offering.”
Additionally, the company is offering free, live educational support group sessions conducted by certified mental health and wellness professionals. (See Hims & Hers stock chart on TipRanks)
Piper Sandler analyst Sean Wieland recently maintained a Hold rating on Hims & Hers with a price target of $11. This implies that shares are fully valued at current levels.
In a research note to investors, the analyst said competition is increasing in the direct-to-consumer online pharmacy segment.
Overall, Hims & Hers has a Moderate Buy consensus rating based on 2 Buys and 2 Holds. The average Hims & Hers Health price target of $13.75 implies 25.3% upside potential from current levels. The company’s shares have lost 30% over the past six months.
Related News:
Kennedy-Wilson Acquires 344-Unit Apartment Community for $65M; Shares Rise 1.6%
Johnson & Johnson’s Vaccine Shows Promising Results Against Delta Variant
Acuity Brands Beats Q3 Earnings Expectations; Shares Down 6%
